Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Pfizer Inc. (NYSE: PFE) announced today that 11 abstracts for tofacitinib will be presented at the European League Against Rheumatism (EULAR) 2013 Annual Meeting being held June 12-15 in Madrid, Spain. The brand name for tofacitinib is XELJANZ® (ZEL’ JANS’).
Help employers find you! Check out all the jobs and post your resume.
